Detalhe da pesquisa
1.
Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer: a phase II study.
Future Oncol
; 18(27): 3011-3020, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920133
2.
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440).
Haematologica
; 106(11): 2834-2844, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121235
3.
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 20(6): 849-861, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31003911
4.
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
Cancer
; 125(10): 1629-1636, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30645764
5.
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer.
Br J Cancer
; 119(10): 1208-1214, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318515
6.
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study.
J Surg Oncol
; 117(3): 354-362, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044544
7.
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.
Oncologist
; 22(3): 264-271, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209746
8.
Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres.
Br J Haematol
; 175(5): 892-903, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27861736
9.
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Invest New Drugs
; 32(4): 700-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24711126
10.
Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study.
BMC Cancer
; 14: 166, 2014 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24606768
11.
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
BMC Cancer
; 14: 5, 2014 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24386952
12.
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.
Pharmacoepidemiol Drug Saf
; 23(7): 726-34, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24830357
13.
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial.
Cancer
; 119(24): 4290-8, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24122767
14.
Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia.
Support Care Cancer
; 21(10): 2853-60, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23748484
15.
Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE).
Cancer
; 118(4): 1083-90, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21800287
16.
Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.
Oncologist
; 17(12): 1486-95, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23015662
17.
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.
Clin Cancer Res
; 28(23): 5040-5048, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194164
18.
Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
Invest New Drugs
; 28(5): 677-83, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19649772
19.
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study.
Oncology
; 78(5-6): 329-39, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20733336
20.
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
Lancet Oncol
; 10(3): 247-57, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19201650